Recombinant tissue plasminogen activator (r-TPA) in fibrin dissolution due to postoperative endophthalmitis
Ann. Acad. Med. Singap. (Online)
; : 723-725, 2006.
Article
in En
| WPRIM
| ID: wpr-275278
Responsible library:
WPRO
ABSTRACT
<p><b>INTRODUCTION</b>The aim of this paper was to describe the use of r-TPA for fibrin clot dissolution following endophthalmitis.</p><p><b>CLINICAL PICTURE</b>A 74-year-old man presented with painful loss of vision following routine uncomplicated cataract surgery.</p><p><b>TREATMENT</b>He underwent standard treatment for postoperative endophthalmitis but despite this, developed a dense fibrin clot. He underwent further intracameral injection of r-TPA.</p><p><b>OUTCOME</b>Following the injection, he had complete clot dissolution within 2 hours without any complications.</p><p><b>CONCLUSION</b>R-TPA may be used effectively in the treatment of fibrin clots secondary to endophthalmitis following cataract surgery.</p>
Full text:
1
Index:
WPRIM
Main subject:
Postoperative Period
/
Recombinant Proteins
/
Fibrin
/
Cataract Extraction
/
Endophthalmitis
/
Tissue Plasminogen Activator
/
Therapeutic Uses
/
Drug Therapy
/
Fibrinolytic Agents
Limits:
Aged
/
Humans
/
Male
Language:
En
Journal:
Ann. Acad. Med. Singap. (Online)
Year:
2006
Type:
Article